Dashboard
Manage Tickers

NRXPNRX Pharmaceuticals, Inc.

Nasdaq nrxpharma.com


$ 3.20 $ 0.21 (7.02 %)    

Tuesday, 14-May-2024 15:59:44 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 445.88 $ 1.10 (0.25 %)
DIA $ 395.58 $ 1.12 (0.28 %)
SPY $ 523.16 $ 2.25 (0.43 %)
TLT $ 90.86 $ 0.51 (0.56 %)
GLD $ 218.12 $ 1.87 (0.86 %)
$ 3.18
$ 3.10
$ 0.00 x 0
$ 0.00 x 0
$ 3.10 - $ 3.20
$ 1.90 - $ 54.00
170,661
na
2.86M
$ 0.82
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-14-2024 03-31-2024 10-Q
2 03-29-2024 12-31-2023 10-K
3 08-14-2023 06-30-2023 10-Q
4 05-15-2023 03-31-2023 10-Q
5 03-31-2023 12-31-2022 10-K
6 11-14-2022 09-30-2022 10-Q
7 08-15-2022 06-30-2022 10-Q
8 05-16-2022 03-31-2022 10-Q
9 03-31-2022 12-31-2021 10-K
10 11-15-2021 09-30-2021 10-Q
11 08-16-2021 06-30-2021 10-Q
12 05-21-2021 03-31-2021 10-Q
13 04-01-2021 12-31-2020 10-K
14 11-16-2020 09-30-2020 10-Q
15 08-14-2020 06-30-2020 10-Q
16 05-15-2020 03-31-2020 10-Q
17 03-30-2020 12-31-2019 10-K
18 11-14-2019 09-30-2019 10-Q
19 08-14-2019 06-30-2019 10-Q
20 05-15-2019 03-31-2019 10-Q
21 03-15-2019 12-31-2018 10-K
22 11-08-2018 09-30-2018 10-Q
23 08-08-2018 06-30-2018 10-Q
24 05-15-2018 03-31-2018 10-Q
25 03-23-2018 12-31-2017 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

nrx-pharmaceuticals-q1-eps-074-misses-037-estimate
NRX Pharmaceuticals Q1 EPS $(0.74) Misses ...
05/14/2024 20:37:04

NRX Pharmaceuticals (NASDAQ:NRXP) reported quarterly losses of $(0.74) per share which missed the analyst consensus estimate of...

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
05/06/2024 16:31:16

nrx-pharmaceuticals-announces-final-clinical-trial-results-believes-demonstration-of-reduced-akathisia-in-setting-of-comparable-antidepressant-efficacy-constitutes-basis-for-accelerated-fda-approval-of-nrx-101
NRx Pharmaceuticals Announces Final Clinic...
05/06/2024 12:33:56

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
05/01/2024 12:06:50

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
04/30/2024 20:31:25

gold-down-over-2-3m-profit-beats-expectations
Gold Down Over 2%; 3M Profit Beats Expecta...
04/30/2024 18:37:24

why-he-equipment-services-shares-are-trading-lower-by-around-18-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why H&E Equipment Services Shares Are Trad...
04/30/2024 17:24:09

12-health-care-stocks-moving-in-tuesdays-intraday-session
12 Health Care Stocks Moving In Tuesday's ...
04/30/2024 16:31:18

why-is-nrx-pharmaceuticals-stock-falling-after-data-from-suicidal-bipolar-depression-study
Why Is NRx Pharmaceuticals Stock Falling A...
04/30/2024 15:46:55

NRX Pharmaceuticals announces Phase 2b/3 trial findings of NRX-101 vs. Lurasidone for Suicidal Bipolar Depression.

nrx-pharmaceuticals-says-both-nrx-101-and-lurasidone-an-accepted-standard-of-care-in-bipolar-depression-demonstrated-approximately-50-reduction-in-symptoms-of-depression
NRx Pharmaceuticals Says 'Both NRX-101 and...
04/30/2024 12:38:52

nrx-pharmaceuticals-announces-findings-in-phase-2b3-clinical-trial-of-nrx-101-vs-lurasidone-for-treatment-of-suicidal-bipolar-depression-says-demonstrated-a-promising-though-not-yet-statistically-significant-33-reduction-in-suicidality-together-with-a-70-reduction-in-symptoms-of-akathisia
NRx Pharmaceuticals Announces Findings In ...
04/30/2024 12:37:57

nasdaq-down-05-lithium-americas-shares-slide
Nasdaq Down 0.5%; Lithium Americas Shares ...
04/18/2024 18:54:52

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
04/18/2024 16:31:41

crude-oil-edges-lower-bio-path-holdings-shares-spike-higher
Crude Oil Edges Lower; Bio-Path Holdings S...
04/18/2024 16:08:16

why-las-vegas-sands-shares-are-trading-lower-by-around-7-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why Las Vegas Sands Shares Are Trading Low...
04/18/2024 15:32:50

dow-surges-over-100-points-dr-horton-posts-upbeat-earnings
Dow Surges Over 100 Points; D.R. Horton Po...
04/18/2024 14:04:48

U.S. stocks traded mixed this morning, with the Dow Jones index gaining more than 100 points on Thursday. Following the market...

nrx-pharmaceuticals-receives-notice-from-nasdaq-that-the-company-has-demonstrated-compliance-with-the-bid-price-requirement
NRx Pharmaceuticals Receives Notice From N...
04/18/2024 12:36:01

The Nasdaq Panel has determined to continue the listing of the Company's securities on The Nasdaq Stock Market and is closi...

nrx-pharmaceuticals-inc-announces-pricing-of-2m-underwritten-public-offering-of-common-stock-at-a-public-offering-price-of-330-per-share
NRx Pharmaceuticals, Inc. Announces Pricin...
04/18/2024 12:35:26

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP), ("NRx Pharmaceuticals" or the "Company"), a clinical-stage biopharmace...

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
04/18/2024 12:09:32

why-alcoa-shares-are-trading-higher-here-are-20-stocks-moving-premarket
Why Alcoa Shares Are Trading Higher; Here ...
04/18/2024 10:28:15

Shares of Alcoa Corporation (NYSE: AA) rose sharply in today’s pre-market trading after the company reported better-than-expec...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION